| 1.39 0.09 (6.92%) | 10-24 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.25  |
1-year : | 2.72 |
| Resists | First : | 1.92 |
Second : | 2.32 |
| Pivot price | 1.48 |
|||
| Supports | First : | 1.27 | Second : | 1.06 |
| MAs | MA(5) : | 1.35 |
MA(20) : | 1.56 |
| MA(100) : | 1.87 |
MA(250) : | 1.63 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 10.3 |
D(3) : | 5.3 |
| RSI | RSI(14): 33.7 |
|||
| 52-week | High : | 2.69 | Low : | 0.77 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ SKIN ] has closed above bottom band by 31.5%. Bollinger Bands are 29.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.4 - 1.41 | 1.41 - 1.42 |
| Low: | 1.29 - 1.3 | 1.3 - 1.31 |
| Close: | 1.37 - 1.39 | 1.39 - 1.41 |
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Thu, 23 Oct 2025
BeautyHealth (NASDAQ: SKIN) schedules Q3 2025 results; webcast and investor call - Stock Titan
Thu, 23 Oct 2025
Beauty Health (NASDAQ:SKIN) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Wed, 22 Oct 2025
Personal Care Q2 Earnings: BeautyHealth (NASDAQ:SKIN) Simply the Best - Yahoo Finance
Sat, 18 Oct 2025
The Beauty Health Company (NASDAQ:SKIN) Receives Average Rating of "Hold" from Analysts - MarketBeat
Tue, 14 Oct 2025
The Beauty Health Company's (NASDAQ:SKIN) 40% Dip In Price Shows Sentiment Is Matching Revenues - 富途牛牛
Tue, 14 Oct 2025
The Market Doesn't Like What It Sees From The Beauty Health Company's (NASDAQ:SKIN) Revenues Yet As Shares Tumble 40% - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Household & Personal Products
|
|
| Shares Out | 127 (M) |
| Shares Float | 82 (M) |
| Held by Insiders | 9.9 (%) |
| Held by Institutions | 86 (%) |
| Shares Short | 17,380 (K) |
| Shares Short P.Month | 15,590 (K) |
| EPS | -0.19 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.57 |
| Profit Margin | -6.2 % |
| Operating Margin | -3.5 % |
| Return on Assets (ttm) | -4.5 % |
| Return on Equity (ttm) | -26.6 % |
| Qtrly Rev. Growth | -13.7 % |
| Gross Profit (p.s.) | 1.5 |
| Sales Per Share | 2.44 |
| EBITDA (p.s.) | -0.13 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 39 (M) |
| Levered Free Cash Flow | 40 (M) |
| PE Ratio | -7.73 |
| PEG Ratio | 0 |
| Price to Book value | 2.39 |
| Price to Sales | 0.56 |
| Price to Cash Flow | 4.47 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|